NYXH Stock — Price, Charts & Analysis

Nyxoah SA (NYXH) has no trailing P/E shown and a forward P/E of -1.69x. This places NYXH in not enough valuation data territory based on the valuation data currently available on Worldtickers.

NYXH trades with -1.69x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether NYXH looks overvalued or undervalued.

NYXH's P/E of -1.69x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

NYXH's trailing EPS is -$2.54 and forward EPS is -$0.97.

EPS, or earnings per share, shows how much profit Nyxoah SA generated for each share. NYXH's trailing EPS is -$2.54, and investors usually prefer EPS that is positive and growing over time.

Nyxoah SA has a market cap of $164.12M, making NYXH a small-cap stock based on the current market value shown on Worldtickers.

NYXH's latest stock price on Worldtickers is $1.64. The latest move is -$0.01 or -0.61%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

NYXH's quote includes a latest price of $1.64. The market open is $1.64. Previous close is $1.65. The intraday range is $1.64 to $1.69.

NYXH is down in the latest quote, with a move of -$0.01 or -0.61%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

NYXH generated $21.66M in trailing revenue. Revenue growth is 472.80%, which helps show whether demand is expanding or slowing.

NYXH's revenue growth is 472.80%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, NYXH does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -$96.00M.

Gross margin is 60.19%. Margins show how efficiently Nyxoah SA turns revenue into profit.

Nyxoah SA carries $59.99M and holds $97.79M in cash.

NYXH holds $97.79M on its balance sheet.

NYXH's book value per share is $0.96.

Institutions hold 30.43% of NYXH shares. Insiders hold 33.78% of shares. Ownership mix helps investors understand how much of Nyxoah SA is held by professional investors and company insiders.

NYXH has 100.07M shares outstanding. Float shares are 50.88M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for NYXH, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for NYXH is -$0.97. Revenue growth is 472.80%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

NYXH's trailing EPS is -$2.54. Forward EPS is -$0.97. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

NYXH is in the Healthcare sector. Its earnings multiple is -1.69x. Its latest displayed growth metric is 472.80%. Compare these figures with sector peers before deciding whether Nyxoah SA is stronger or weaker than average.

NYXH trades at $1.64. The stock trades at -1.69x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Nyxoah SA's fundamentals.

NYXH risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.95, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

NYXH should be compared with companies in Medical Instruments & Supplies. Its earnings multiple is -1.69x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Nyxoah SA (NYXH) operates in Healthcare, specifically Medical Instruments & Supplies. Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

NYXH trades on NasdaqGM. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

NYXH stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Nyxoah SA's official website listed on Worldtickers is www.nyxoah.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Nyxoah SA employs about 153 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Nyxoah SA is headquartered in Mont-Saint-Guibert, Belgium. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

NYXH is in the Healthcare sector and the Medical Instruments & Supplies industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

NYXH has traded between $1.26 and $6.88 over the past 52 weeks. At $1.64, it is 76.15% below the high and 30.16% above the low. The 52-week range helps gauge long-term price momentum.

NYXH is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is $1.56 and its 200-day moving average is $3.40.

NYXH's RSI is 55.94. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

NYXH's latest RSI reading is 55.94, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for NYXH is near $1.30. Key resistance is near $1.67. Breaks above resistance or below support can change the short-term technical setup.

NYXH's nearest reported support level is $1.30. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

NYXH's nearest reported resistance level is $1.67. A breakout above resistance can improve momentum, especially when volume confirms the move.

NYXH trades about 329.74K shares daily on average. The latest displayed volume is 39.12K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

NYXH's MACD is 0.04, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

NYXH is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 55.94 (neutral). MACD is bullish. Nearest support is around $1.30. Resistance is around $1.67. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $1.49 (9.88% from price). MA50 is $1.56 (5.47% from price). MA200 is $3.40 (-51.73% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. NYXH's MA20 is $1.49. MA50 is $1.56. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

NYXH's pivot is near $1.64. Support is near $1.30. Resistance is near $1.67. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for NYXH is near $1.51. The next upper resistance zone is near $1.86. These levels help define risk and possible follow-through zones after a breakout or breakdown.

NYXH's Bollinger range is roughly $1.29 to $1.69. Band width is near 26.79%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

NYXH's ATR-based typical daily range is about 5.14%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 39.12K shares. Average volume is about 329.74K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

NYXH's all-time high shown on Worldtickers is $37.00. Its all-time low is $1.26. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

NYXH has a beta of 0.95, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.